Development, implementation, and evaluation of a ketoconazole practice guideline for ARDS prophylaxis

Journal of Critical Care

Volumn 14, Issue 1, 1999, Pages 1-6

  Sinuff, Tasnim ^b   Cook, Deborah J ^a   Peterson, John C ^b   Fuller, Hugh D ^b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; KETOCONAZOLE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; CRITICAL ILLNESS; FEMALE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MALE; MORTALITY; PRACTICE GUIDELINE;

EID: 0033060336     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0883-9441(99)90001-1     Document Type: Article

References (39)

1. Bernard GR, Artigas A, Brigham KL, et al: The Consensus Committee: Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med 20:225-232, 1994
2. Tate RM, Repine JE: Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 100:1397-1403, 1994
3. Bernard GR, Brigham KL: Adult respiratory distress syndrome. Am Rev Med 36:195-205, 1985
4. Downey GP, Granton JT: Mechanisms of acute lung injury. Current Opinion in Critical Care Medicine 3:43-50, 1997
5. Pepe PE, Potkin RT, Reus DH, et al: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124-130, 1982
6. Sloane PJ, Gee JH, Gottlieb JE, et al: A multicenter registry of patients with acute respiratory distress syndrome. Am Rev Respir Dis 146:419-426, 1992
7. Osborne ML: Physician decisions regarding life support in the intensive care unit. Chest 101:214-224, 1992
8. Matthay MA, Szaflarski N, Modin G, et al: Prospective study of 123 patients with acute lung injury: Predictors of mortality. Am Rev Respir Dis 147:A348, 1993
9. Hebert PC, Drummond AJ, Singer J, et al: A simple multiple organ system failure scoring system predicts mortality of patients who have sepsis syndrome. Chest 104:230-235, 1993
10. Bone RC, Balk R, Slotman G: Adult respiratory distress syndrome and importance of multiple organ failure. Chest 101:320-326, 1992
11. Hudson LD: New therapies for ARDS. Chest 108:79S-91S, 1995
12. Bernard GR, Luce JM, Sprung CL, et al: High dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565-1570, 1987
13. Weigelt JA, Norcross JF, Borman KR, et al: Early steroid therapy for respiratory failure. Arch Surg 120:530-535, 1985
14. Bone RC, Fisher CJ, Clemmer TP, et al: Early methylprednisilone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92:1032-1036, 1987
15. Steinberg SM, Rodriguez JL, Bitzer LG, et al: Indomethacin treatment of human adult respiratory distress syndrome. Circ Shock 30:375-384, 1990
16. Bernard GR, Reines HD, Metz CA, et al: Effects of a short course of ibuprofen in patients with severe sepsis. Am Rev Respir Dis 137, A138, 1988
17. Shoemaker WC, Appel PL: Effects of prostaglandin E1 in adult respiratory distress syndrome. Surgery 99:275-283, 1986
18. Bone RC, Slotman G, Maunder R, et al: Randomized double blind, multicenter study of prostaglandin E1 in patients with adult respiratory distress syndrome. Chest 96:114-119, 1989
19. Greeman RL, Schein RM, Martin MA, et al: A controlled trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram negative sepsis. The XOMA Sepsis Study Group. JAMA 266:1097-1102, 1991
20. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al: Treatment of gram negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 324:429-436, 1991
21. Fisher CJ Jr, Opal SM, Dhainaut JF, et al: Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21:318-337, 1993
22. Fisher CJ Jr, Dhainaut JF, Stephens S: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results form a randomized double-blind, placebo-controlled trial: Phase III rhIL-1 ra. Sepsis Syndrome Study Group. JAMA 271:1836-1843, 1994
23. Bernard GR, Reines HD, Halushka P, et al: Prostacycline and thromboxane A2 formation is increased in human sepsis syndrome. Am Rev Respir Dis 144:1095-1101, 1991
24. Lelcuk S, Huval WV, Valeri CR, et al: Inhibition of ischemia induced thromboxane synthesis in man. J Trauma 24:393-396, 1984
25. Slotman GJ, Burchard KW, D'Arezzo A, et al: Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 28:648-652, 1988
26. Yu M, Tomasa G: A double-blind prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 21:1635-1642, 1993
27. Antman EM, Lau J, Kupelnick B, et al: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: Treatments for myocardial infarction. JAMA 268:240-248, 1992
28. Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine, in Field MJ, Lohr KN (eds): Clinical Practice Guidelines: Directions of a New Program. National Academy Press, Washington, DC, 1990
29. Cook DJ, Greengold NL, Ellrodt AG, et al: The relation between systematic reviews and practice guidelines. Ann Intern Med 127:210-216, 1997
30. Roche N, Durieux P: Clinical practice guidelines: From methodological to practical issues. Intensive Care Med 20:593-601, 1994
31. Grimshaw JM, Russell IT: Effect of clinical practice guidelines on medical practice: A systematic review of rigorous evaluations. Lancet 342:1317-1322, 1983
32. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1991
33. Sauve S, Lee HN, Meade MO, et al: The critically appraised topic: A practical approach to learning critical appraisal. Annals of the Royal College of Physicians and Surgeons of Canada 28:396-398, 1995
34. Weingarten S, Riedinger MS, Conner L, et al: Practice guidelines and reminders to reduce duration of hospital stay for patients with chest pain: An interventional trial. Ann Intern Med 120:257-263, 1994
35. Davis DA, Thomson MA, Oxman AD, et al: Changing physician performance: A systematic review of the effect of continuing medical educational strategies. JAMA 274:700-705, 1995
36. Sinuff T, Peterson JC, Caldwell S, et al: Prospective analysis of a ketoconazole practice guideline implementation for Adult Respiratory Distress Syndrome prophylaxis. Chest 112:585, 1997 (abstr)
37. Sonino H: The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 317:812-818, 1987
38. Pettignano R, Chambliss CR, Darsey E, et al: Cisapride induced dysrhythmia in a pediatric patient receiving extracorporeal life support. Crit Care Med 24:1268-1271, 1996
39. Chan-Tompkins NH, Babinchak TJ: Cardiac arrhythmias associated with co-administration of azo compounds and cisapride. Clin Infect Dis 24:1285, 1997